IP Library Granted Patent US 11,649,439
Granted Patent B2
US 11,649,439 · App. 17/071,693 · Granted May 16, 2023

Biologic composition and method of manufacture

Inventors: Timothy Ganey (Tampa, FL); Wendy W. Weston (Miami, FL); Miguel Quevedo (Miami, FL); Stuart Oglesby (Miami, FL); Gaetan Jean-Robert Delcroix (Miami, FL); Paul C. Schiller (Miami Beach, FL); Gianluca D'Ippolito (North Miami Beach, FL)
Assignee: Vivex Biologies Group, Inc.
C12N5/0669A01N1/0221A01N1/0284A61K35/28A61K35/32A61L27/3604A61L27/365A61L27/3608A61L27/3691A61L27/3834A61L27/446A61L27/50A61L27/54A61L27/58C08L89/00A61K2035/124A61K2300/00A61L2430/00A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,649,439
App. No.
17/071,693
Granted
May 16, 2023
Kind
B2
Abstract

A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture is compatible with biologic function.

Claims (11)

1. A method of preparing a biological composition, comprising:

a) obtaining cadaverous bone including cortical bone, cancellous bone, and bone marrow cut from a vertebral body of a cadaver donor;

b) mechanically separating cellular and non-cellular components of the bone marrow from cadaverous bone by tumbling, sieving the cadaverous bone from a decanted fluid of the bone marrow containing the cellular and non-cellular components in a series of cycles, wherein in a first cycle, the decanted fluid is discarded, and in subsequent cycles, the decanted fluid is collected and comingled to form the decanted fluid;

c) concentrating the decanted fluid by centrifugation and filtering the decanted fluid through a blood filter to form a mixture including the cellular and non-cellular components separated from the marrow tissue and remaining cancellous and cortical bone;

d) separating the mixture by density gradient centrifugation to form an interface of the cellular and non-cellular components;

e) collecting from the interface the cells or non-cellular components or combinations thereof;

f) washing the cells or non-cellular components or combination thereof in the mixture wherein the interface is collected using a pipette and transferred into tubes ensuring no tube has more than 10 ml in volume of the interface, each tube is filled to 50 ml by adding DPBS and centrifuged forming a supernatant and a pellet, wherein the supernatant is removed leaving the pellet in the tube, each tube is then filled up to 50 ml with DPBS to resuspend the pellet, another centrifugation occurs and the supernatant is removed and the remaining pellet is resuspended using process media with no antibiotics;

g) suspending the mixture in a cryoprotectant to create the biological composition suitable for direct implantation in a subject without washing or rinsing; and

h) freezing the biological composition.

2. The method of claim 1 , further comprising packaging the frozen biological composition and packaging a volume of bone separate from the composition.

3. The method of claim 1 , further comprising adding a volume of bone to the mixture of step f) or the biological composition of step g) prior to freezing the biological composition.

Assignments (1)
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →